We therefore hypothesized that important snoRNAs may be involved in the progression of HCC by regulating the PI3K/AKT/mTOR cascade, and that characterizing its mechanism may help reveal potential therapeutic targets for HCC. This evidence concerns the gene MTOR and hepatocellular carcinoma.